Release Date: 30/04/10 17:14 Summary: Change of Director's Interest Notice x2 Price Sensitive: No Download Document 182.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%